Scott Moe
28Patents
10h-index
65Co-inventors
78Inventor score
Filing activity: Jan 22, 1993 → Oct 28, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6660753B2 | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | Chemistry; Metallurgy | 115 | Expired |
| US6211244A | Calcium receptor-active compounds | Physics | 111 | Expired |
| US6031003A | Calcium receptor-active molecules | Physics | 72 | Expired |
| US6011068A | Calcium receptor-active molecules | Physics | 66 | Expired |
| US7112595B2 | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | Chemistry; Metallurgy | 63 | Expired |
| US6001884A | Calcium receptor-active molecules | Physics | 49 | Expired |
| US6071970A | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | Chemistry; Metallurgy | 47 | Expired |
| US6429207B1 | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases | Chemistry; Metallurgy | 40 | Expired |
| US5981599A | Inorganic ion receptor active compounds | Chemistry; Metallurgy | 34 | Expired |
| US7501404B2 | Substituted azetidinones | Chemistry; Metallurgy | 14 | Expired |
| US6017965A | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | Chemistry; Metallurgy | 10 | Expired |
| US5298622A | Spiroindane opiate analogs | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6306912A | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | Physics | 7 | Expired |
| US7053104B2 | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases | Chemistry; Metallurgy | 7 | Expired |
| US6342532B1 | Inorganic ion receptor active compounds | Chemistry; Metallurgy | 6 | Expired |
| US6051610A | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | Chemistry; Metallurgy | 5 | Expired |
| US5258384A | S-11-hydroxy-10-methylaporphine and its biologically active salt forms as 5HT.sub.1A inhibitors | Chemistry; Metallurgy | 4 | Expired |
| US11931347B2 | Method of screening for agents for differentiating stem cells | Physics | 3 | Active |
| US6710088B2 | Inorganic ion receptor-active compounds | Chemistry; Metallurgy | 3 | Expired |
| US6617358B1 | Anticonvulsant and central nervous system-depressing bis(fluorophenyl)alkylamides and their uses | Chemistry; Metallurgy | 3 | Expired |
| US7345048B2 | Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US6211245A | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | Chemistry; Metallurgy | 1 | Expired |
| US12104170B2 | Methods for deriving dopaminergic neurons from pluripotent stem cells | Chemistry; Metallurgy | 1 | Active |
| US7087765B2 | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | Chemistry; Metallurgy | 0 | Expired |
| US8586552B2 | 4,6-substituted 2,5-dideoxystreptamine aminoglycoside antibiotics | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.